Affiliation:
1. Research Institute — Ochapovsky Regional Clinical Hospital № 1
2. Research Institute — Ochapovsky Regional Clinical Hospital № 1; Kuban State Medical University
Abstract
A case report is devoted to the successful management of a 33-year-old patient with subacute infective endocarditis of the tricuspid valve and pacemaker, as well as chronic thromboembolic pulmonary hypertension. There were following therapy stages: 1) pharmacotherapy — antimicrobial agents, treatment of heart failure, pulmonary hypertension; 2) an interventional approach — tricuspid valve replacement with chamber sanitation, pacemaker explantation, endocardial lead removal from the right heart, implantation of a pacemaker with an epicardial lead system and 3) delayed balloon pulmonary angioplasty.
Subject
Cardiology and Cardiovascular Medicine
Reference15 articles.
1. Blinova VV, Panteleeva EA, Mironova AA, et al. Pulmonary embolism as a complication of permanent electrocardiostimulation. Practical medicine. 2020;18(1):116-9. (In Russ.) doi:10.32000/2072-1757-2020-1-116-119.
2. Humbert M, Kovacs G, Hoeper MM, et al. ESC/ERS Scientific Document Group. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J. 2022;43(38):3618-731. doi:10.1093/eurheartj/ehac237.
3. Noheria A, Ponamgi SP, Desimone CV, et al. Pulmonary embolism in patients with transvenous cardiac implantable electronic device leads. Europace. 2016;18(2):246-52. doi:10.1093/europace/euv038.
4. Liesenborghs L, Meyers S, Vanassche T, et al. Coagulation: At the heart of infective endocarditis. J Thromb Haemost. 2020;18(5):995-1008. doi:10.1111/jth.14736.
5. Martyniuk TV, Dadacheva ZK, Chazova IE. Possibilities of medical treatment of chronic thromboembolic pulmonary hypertension. Aterotromboz. 2015;(1):87-98. (In Russ.) doi:10.21518/2307-1109-2015-1-30-40.